List of Excipients in API ziprasidone mesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ziprasidone mesylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Roerig | GEODON | ziprasidone mesylate | 0049-1203 | BETADEX SULFOBUTYL ETHER SODIUM | |
| Roerig | GEODON | ziprasidone mesylate | 0049-1203 | METHANESULFONIC ACID | |
| A-S Medication Solutions | GEODON | ziprasidone mesylate | 50090-4540 | BETADEX SULFOBUTYL ETHER SODIUM | |
| A-S Medication Solutions | GEODON | ziprasidone mesylate | 50090-4540 | METHANESULFONIC ACID | |
| TYA Pharmaceuticals | GEODON | ziprasidone mesylate | 64725-3920 | METHANESULFONIC ACID | |
| TYA Pharmaceuticals | GEODON | ziprasidone mesylate | 64725-3920 | SULFOBUTYLETHER .BETA.-CYCLODEXTRIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ziprasidone mesylate
Detailed excipient profiles for ziprasidone mesylate
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
ziprasidone mesylate drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
ziprasidone mesylate drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| TYA Pharmaceuticals | ziprasidone mesylate | 64725-3920 |
| Novadoz Pharmaceuticals LLC | ziprasidone mesylate | 72205-205 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHANESULFONIC ACID
ziprasidone mesylate drug variants containing METHANESULFONIC ACID
ziprasidone mesylate drug variants not containing METHANESULFONIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
ziprasidone mesylate drug variants containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| TYA Pharmaceuticals | ziprasidone mesylate | 64725-3920 |
| Novadoz Pharmaceuticals LLC | ziprasidone mesylate | 72205-205 |
| >Company | >Ingredient | >NDC |
ziprasidone mesylate drug variants not containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
